What is CareCloud's operating income?

CareCloud's total operating income in 2025 was $11.34 million, based on the following breakdown: Total Gross Profit: $120.50 million Total Operating Expenses: $109.16 million

CareCloud (CCLD) Financials

$2.32 -0.06 (-2.52%)

Closing price 07/14/2026 04:00 PM Eastern

Extended Trading

$2.28 -0.04 (-1.94%)

As of 08:30 AM Eastern

Compare

Annual Income Statements for CareCloud

This table shows CareCloud's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-4.89	-9.55	-7.60	-6.96	-7.26	-23	-11	-10	-64	-4.46	3.89
Consolidated Net Income / (Loss)	-4.69	-8.80	-5.57	-2.14	-0.87	-8.81	2.84	5.43	-49	7.85	11
Net Income / (Loss) Continuing Operations	-4.69	-8.80	-5.57	-2.14	-0.87	-8.81	2.84	5.43	-49	7.85	11
Total Pre-Tax Income	-4.55	-8.60	-5.50	-2.30	-0.68	-8.71	2.99	5.61	-49	8.01	11
Total Operating Income	-4.46	-7.90	-4.52	-2.54	0.07	-8.27	3.53	6.61	-47	9.12	11
Total Gross Profit	23	24	32	51	64	105	140	139	46	111	120
Total Revenue	23	24	32	51	64	105	140	139	117	111	120
Operating Revenue	23	24	32	51	64	105	140	139	117	111	120
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	71	0.00	0.00
Total Operating Expenses	28	32	36	53	64	113	136	132	93	102	109
Selling, General & Admin Expense	12	12	12	16	18	23	24	108	21	77	83
Marketing Expense	0.47	1.22	1.11	1.61	1.52	6.58	8.79	9.79	9.65	6.23	4.82
Research & Development Expense	0.66	0.90	1.08	1.03	0.87	9.31	4.41	4.40	4.74	3.78	6.38
Depreciation Expense	4.60	5.11	4.30	2.85	3.01	9.91	12	12	14	14	15
Restructuring Charge	-	0.00	0.28	0.00	0.22	-	-	1.14	1.11	0.60	0.15
Total Other Income / (Expense), net	-0.09	-0.70	-0.98	0.24	-0.75	-0.44	-0.54	-1.00	-1.92	-1.11	-0.35
Interest Expense	0.29	0.68	1.32	0.35	0.38	0.49	0.46	0.41	1.19	0.90	0.29
Interest & Investment Income	0.03	0.04	0.02	0.10	0.26	0.04	0.02	0.04	0.15	0.09	0.21
Other Income / (Expense), net	0.17	-0.05	0.33	0.49	-0.63	0.01	-0.10	-0.64	-0.88	-0.30	-0.27
Income Tax Expense	0.14	0.20	0.07	-0.16	0.19	0.10	0.16	0.18	-0.36	0.16	0.20
Preferred Stock Dividends Declared	0.21	0.75	2.03	4.82	6.39	14	14	16	16	12	6.91
Basic Earnings per Share	-	($0.95)	($0.69)	($0.59)	($0.60)	($1.79)	($0.77)	($0.67)	($4.11)	($0.28)	$0.10
Weighted Average Basic Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.11M	15.67M	16.15M	37.79M
Diluted Earnings per Share	-	($0.95)	($0.69)	($0.59)	($0.60)	($1.79)	-	($0.67)	($4.11)	($0.28)	$0.10
Weighted Average Diluted Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.11M	15.67M	16.15M	37.95M
Weighted Average Basic & Diluted Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.51M	16.12M	42.32M	42.49M

This table shows CareCloud's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-6.67	-48	-1.55	-2.25	-0.67	0.01	-0.86	1.54	1.70	1.52	-0.44
Consolidated Net Income / (Loss)	-2.75	-44	-0.24	1.67	3.12	3.30	1.95	2.90	3.06	2.89	0.92
Net Income / (Loss) Continuing Operations	-2.75	-44	-0.24	1.67	3.12	3.30	1.95	2.90	3.06	2.89	0.92
Total Pre-Tax Income	-2.69	-44	-0.20	1.71	3.16	3.34	1.99	2.94	3.10	2.96	0.97
Total Operating Income	-1.97	-44	0.13	2.27	3.27	3.46	2.02	3.00	3.21	3.12	1.00
Total Gross Profit	11	11	11	13	13	74	28	13	15	81	31
Total Revenue	29	28	26	28	29	28	28	27	31	34	31
Operating Revenue	29	28	26	28	29	28	28	27	31	34	31
Total Cost of Revenue	18	17	15	15	15	-46	0.00	14	16	-46	0.00
Total Operating Expenses	13	55	11	11	9.86	71	26	9.90	12	77	30
Selling, General & Admin Expense	5.48	4.95	3.72	4.03	4.38	65	20	4.36	4.89	69	22
Marketing Expense	2.34	2.12	1.77	1.66	1.38	1.42	1.13	1.12	1.12	1.45	1.41
Research & Development Expense	1.26	1.21	0.91	1.06	0.80	1.01	1.24	1.02	1.58	2.54	2.42
Depreciation Expense	3.90	4.12	3.93	3.71	3.24	3.26	3.34	3.38	4.02	4.22	4.04
Restructuring Charge	0.01	0.68	0.32	0.12	0.07	0.09	0.11	0.02	0.02	-	0.00
Other Special Charges / (Income)	-	-	-	-	-	-	0.00	-	-	-	0.06
Total Other Income / (Expense), net	-0.72	-0.63	-0.33	-0.56	-0.10	-0.12	-0.03	-0.05	-0.11	-0.16	-0.03
Interest Expense	0.35	0.37	0.37	0.29	0.18	0.07	0.06	0.07	0.15	0.01	0.06
Interest & Investment Income	0.05	0.03	0.03	0.02	0.02	0.02	0.04	0.05	0.10	0.02	0.01
Other Income / (Expense), net	-0.42	-0.29	0.01	-0.29	0.06	-0.07	-0.01	-0.04	-0.06	-0.16	0.02
Income Tax Expense	0.06	-0.57	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.07	0.05
Preferred Stock Dividends Declared	3.92	3.92	1.31	3.92	3.79	3.29	2.81	1.37	1.37	1.37	1.37
Basic Earnings per Share	($0.42)	($3.04)	($0.10)	($0.14)	($0.04)	-	($0.04)	$0.04	$0.04	$0.06	($0.01)
Weighted Average Basic Shares Outstanding	15.76M	15.67M	16.01M	16.13M	16.20M	16.15M	23.81M	42.32M	42.37M	37.79M	42.47M
Diluted Earnings per Share	($0.42)	($3.04)	($0.10)	($0.14)	($0.04)	-	($0.04)	$0.04	$0.04	$0.06	($0.01)
Weighted Average Diluted Shares Outstanding	15.76M	15.67M	16.01M	16.13M	16.20M	16.15M	23.81M	42.32M	42.37M	37.95M	42.47M
Weighted Average Basic & Diluted Shares Outstanding	15.87M	16.12M	16.12M	16.21M	16.24M	42.32M	42.32M	42.32M	42.40M	42.49M	42.49M

This table details how cash moves in and out of CareCloud's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	6.99	-4.56	0.89	10	4.88	0.93	-11	1.96	-8.97	1.81	-1.53
Net Cash From Operating Activities	-1.88	-0.89	0.28	6.81	7.62	-0.89	13	21	15	21	29
Net Cash From Continuing Operating Activities	-1.88	-0.89	0.28	6.81	7.62	-0.89	13	21	15	21	29
Net Income / (Loss) Continuing Operations	-4.69	-8.80	-5.57	-2.14	-0.87	-8.81	2.84	5.43	-49	7.85	11
Consolidated Net Income / (Loss)	-4.69	-8.80	-5.57	-2.14	-0.87	-8.81	2.84	5.43	-49	7.85	11
Depreciation Expense	4.60	5.11	4.30	2.91	3.07	10	13	12	15	14	15
Amortization Expense	-	-	-	0.00	1.89	2.89	3.57	3.29	2.15	1.99	1.77
Non-Cash Adjustments To Reconcile Net Income	0.79	2.43	2.33	2.48	5.06	7.49	6.72	7.19	48	1.63	1.09
Changes in Operating Assets and Liabilities, net	-2.58	0.37	-0.79	3.56	-1.53	-13	-12	-7.07	-1.03	-5.31	-0.30
Net Cash From Investing Activities	-0.60	-3.83	-0.90	-14	-4.16	-31	-23	-12	-12	-7.41	-25
Net Cash From Continuing Investing Activities	-0.60	-3.83	-0.90	-14	-4.16	-31	-23	-12	-12	-7.41	-25
Purchase of Property, Plant & Equipment	-0.42	-0.46	-0.70	-1.03	-2.56	-7.75	-11	-2.59	-3.06	-1.70	-4.78
Acquisitions	-0.18	-3.37	-0.21	-13	-1.60	-24	-13	-	-	0.00	-17
Other Investing Activities, net	-	-	-	-	-	-	-	-9.18	-8.55	-5.71	-3.25
Net Cash From Financing Activities	9.50	0.15	1.84	18	1.42	33	-0.52	-7.65	-13	-11	-5.61
Net Cash From Continuing Financing Activities	9.50	0.15	1.84	18	1.42	33	-0.52	-7.65	-13	-11	-5.61
Repayment of Debt	-12	-7.58	-24	-12	-0.48	-20	-19	-27	-14	-11	-9.96
Payment of Dividends	-0.05	-0.71	-1.49	-4.10	-6.11	-11	-14	-15	-14	0.00	-6.30
Issuance of Debt	17	7.91	9.20	11	0.00	20	26	26	15	0.00	11
Other Financing Activities, net	0.00	-0.20	-0.34	-0.48	-1.58	0.93	4.31	-2.20	-1.52	-0.58	-0.15
Effect of Exchange Rate Changes	-0.03	0.01	-0.34	-	-	-0.13	-0.25	0.23	0.47	-0.17	0.06
Cash Interest Paid	0.26	0.45	0.61	0.06	0.07	0.17	0.10	0.16	0.93	0.68	0.23
Cash Income Taxes Paid	0.01	0.05	0.01	0.04	0.12	0.09	0.28	0.15	0.14	0.16	0.25

This table details how cash moves in and out of CareCloud's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-1.26	-3.08	0.81	-1.52	0.17	2.36	1.66	3.64	-5.37	-1.46	0.24
Net Cash From Operating Activities	4.31	3.74	4.07	4.28	7.07	5.23	5.11	7.41	7.37	8.68	3.61
Net Cash From Continuing Operating Activities	4.31	3.74	4.07	4.28	7.07	5.23	5.11	7.41	7.37	8.68	3.61
Net Income / (Loss) Continuing Operations	-2.75	-44	-0.24	1.67	3.12	3.30	1.95	2.90	3.06	2.89	0.92
Consolidated Net Income / (Loss)	-2.75	-44	-0.24	1.67	3.12	3.30	1.95	2.90	3.06	2.89	0.92
Depreciation Expense	4.01	4.22	4.02	3.80	3.32	3.33	3.41	3.45	4.08	4.27	4.09
Amortization Expense	0.47	0.53	0.51	0.50	0.49	0.49	0.48	0.42	0.42	0.45	0.46
Non-Cash Adjustments To Reconcile Net Income	1.77	43	-0.88	1.11	0.68	0.71	0.18	0.84	0.48	-0.41	0.43
Changes in Operating Assets and Liabilities, net	0.82	-0.73	0.65	-2.81	-0.55	-2.60	-0.90	-0.20	-0.67	1.48	-2.29
Net Cash From Investing Activities	-3.25	-2.29	-1.87	-1.60	-1.67	-2.26	-1.51	-1.99	-18	-3.34	-1.23
Net Cash From Continuing Investing Activities	-3.25	-2.29	-1.87	-1.60	-1.67	-2.26	-1.51	-1.99	-18	-3.34	-1.23
Purchase of Property, Plant & Equipment	-1.07	-0.38	-0.30	-0.13	-0.33	-0.94	-0.62	-1.16	-0.87	-2.12	-0.41
Acquisitions	-	-	0.00	-	-	-	-0.04	-	-16	-0.47	0.00
Other Investing Activities, net	-2.18	-1.92	-1.57	-1.48	-1.34	-1.32	-0.85	-0.83	-0.83	-0.74	-0.82
Net Cash From Financing Activities	-2.58	-4.88	-1.37	-4.14	-5.17	-0.58	-1.93	-1.76	4.92	-6.84	-2.15
Net Cash From Continuing Financing Activities	-2.58	-4.88	-1.37	-4.14	-5.17	-0.58	-1.93	-1.76	4.92	-6.84	-2.15
Repayment of Debt	-0.40	-2.17	-1.22	-4.11	-5.15	-0.20	-0.18	-0.17	-1.87	-7.74	-0.18
Payment of Dividends	-3.91	-2.61	0.00	-	-	-	-1.73	-1.59	-1.50	-1.47	-1.92
Other Financing Activities, net	-0.26	-0.10	-0.15	-0.03	-0.02	-0.38	-0.02	-0.00	-0.05	-0.07	-0.06
Effect of Exchange Rate Changes	0.25	0.36	-0.02	-0.06	-0.06	-0.03	-0.01	-0.02	0.05	0.04	0.01
Cash Interest Paid	0.29	0.30	0.30	0.23	0.12	0.04	0.02	0.03	0.02	0.16	0.02
Cash Income Taxes Paid	0.02	0.01	0.01	0.12	0.02	0.01	0.02	0.13	0.03	0.07	0.01

This table presents CareCloud's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	27	28	26	48	56	138	141	136	78	72	88
Total Current Assets	11	8.44	8.93	26	31	45	36	35	23	25	26
Cash & Equivalents	8.04	3.48	4.36	14	20	21	9.34	12	3.33	5.15	3.12
Restricted Cash	-	-	-	-	-	0.00	1.00	-	-	0.00	0.50
Accounts Receivable	2.23	4.34	3.90	7.36	7.01	12	17	15	12	13	15
Inventories, net	-	-	0.00	0.44	0.49	0.40	0.50	0.38	0.47	0.57	0.51
Prepaid Expenses	0.62	0.62	0.66	1.19	1.12	7.29	2.97	2.79	2.45	1.96	2.87
Other Current Assets	-	-	0.00	2.61	2.39	4.11	4.74	4.40	5.09	4.33	3.66
Plant, Property, & Equipment, net	1.37	1.59	1.39	1.83	2.91	4.92	5.40	5.06	5.32	5.29	7.78
Total Noncurrent Assets	14	18	15	20	22	88	100	96	49	42	54
Goodwill	8.97	12	12	13	13	49	61	61	19	19	31
Intangible Assets	5.38	5.83	2.51	6.63	5.98	30	31	30	25	19	19
Other Noncurrent Operating Assets	0.07	0.28	0.44	0.49	3.88	8.99	7.92	5.76	5.01	3.64	3.68
Total Liabilities & Shareholders' Equity	27	28	26	48	56	138	141	136	78	72	88
Total Liabilities	12	21	5.28	8.75	14	37	43	34	36	22	28
Total Current Liabilities	5.76	16	4.32	8.16	11	29	30	22	23	20	24
Short-Term Debt	3.83	10	0.67	0.80	0.28	0.40	1.34	0.32	0.29	0.31	1.64
Accounts Payable	0.37	1.91	0.99	2.44	3.49	6.46	5.95	5.68	5.80	4.57	6.94
Accrued Expenses	1.29	3.26	1.76	1.60	2.11	8.50	5.09	4.43	5.07	4.95	5.97
Dividends Payable	0.16	0.20	0.75	1.47	1.75	4.24	3.86	4.06	5.43	5.44	0.67
Current Deferred Revenue	0.11	0.10	0.14	0.12	0.02	1.17	1.09	1.39	1.38	1.21	4.15
Current Employee Benefit Liabilities	-	-	-	1.73	1.84	2.59	4.25	4.25	3.44	1.82	4.14
Other Current Liabilities	-	-	-	0.00	1.69	4.73	7.05	2.27	1.89	1.29	0.93
Total Noncurrent Liabilities	6.03	5.40	0.95	0.60	2.39	7.73	13	12	13	2.26	3.67
Long-Term Debt	4.90	4.20	0.12	0.22	0.08	0.04	8.02	8.01	10	0.03	0.44
Noncurrent Deferred Revenue	0.53	0.46	0.36	0.21	0.02	0.31	0.34	0.34	0.26	0.39	0.81
Other Noncurrent Operating Liabilities	0.43	0.39	0.10	0.00	2.04	6.30	4.55	3.21	2.52	1.85	2.42
Commitments & Contingencies	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	15	7.07	20	39	43	101	98	102	42	50	60
Total Preferred & Common Equity	15	7.07	20	39	43	101	98	102	42	50	60
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.00
Total Common Equity	15	7.07	20	39	43	101	98	102	42	50	60
Common Stock	25	26	45	65	69	137	131	131	121	121	120
Retained Earnings	-9.15	-18	-24	-24	-25	-34	-31	-26	-74	-67	-56
Treasury Stock	-0.12	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-	-0.66
Accumulated Other Comprehensive Income / (Loss)	-0.40	-0.38	-0.72	-1.42	-0.84	-1.00	-1.75	-3.04	-3.87	-4.00	-3.98

This table presents CareCloud's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	126	77	74	71	74	75	91	87
Total Current Assets	27	24	24	23	29	31	29	26
Cash & Equivalents	6.41	4.14	2.62	2.78	6.81	10	4.26	3.35
Restricted Cash	-	-	-	-	-	-	0.82	0.50
Accounts Receivable	12	12	13	12	14	14	15	15
Inventories, net	0.48	0.48	0.50	0.51	0.61	0.52	0.61	0.43
Prepaid Expenses	3.30	2.23	2.91	2.74	2.84	2.59	4.29	3.05
Other Current Assets	4.95	5.46	4.80	4.62	4.46	3.96	3.96	3.50
Plant, Property, & Equipment, net	5.32	5.44	5.06	4.89	5.32	5.83	6.31	7.46
Total Noncurrent Assets	93	47	45	43	40	38	55	53
Goodwill	61	19	19	19	19	19	30	31
Intangible Assets	27	23	21	20	17	16	21	17
Other Noncurrent Operating Assets	5.24	4.75	4.36	3.85	3.55	3.62	3.33	5.24
Total Liabilities & Shareholders' Equity	126	77	74	71	74	75	91	87
Total Liabilities	38	35	31	24	19	19	33	28
Total Current Liabilities	22	24	23	22	17	16	23	23
Short-Term Debt	0.49	0.17	0.07	0.51	0.18	0.55	0.93	1.48
Accounts Payable	6.24	5.92	5.45	5.57	4.95	4.22	6.69	5.51
Accrued Expenses	4.63	6.35	6.62	5.14	5.00	4.91	5.67	5.95
Dividends Payable	4.13	5.44	5.44	5.44	1.30	0.71	0.71	0.94
Current Deferred Revenue	1.53	1.39	1.22	1.31	1.30	1.23	4.27	4.75
Current Employee Benefit Liabilities	3.12	2.77	2.82	2.55	2.87	3.32	3.83	3.48
Other Current Liabilities	1.81	1.78	1.62	1.42	1.36	1.29	1.11	1.36
Total Noncurrent Liabilities	16	12	7.52	2.26	2.43	2.93	9.57	4.93
Long-Term Debt	12	9.04	5.03	0.03	0.02	0.09	6.73	0.25
Noncurrent Deferred Revenue	0.42	0.31	0.39	0.33	0.57	0.63	0.73	0.89
Other Noncurrent Operating Liabilities	2.79	2.32	2.10	1.90	1.84	2.21	2.11	3.79
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	88	41	43	47	54	56	58	58
Total Preferred & Common Equity	88	41	43	47	54	56	58	58
Preferred Stock	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Total Common Equity	88	41	43	47	54	56	58	58
Common Stock	124	121	121	121	124	123	121	118
Retained Earnings	-31	-75	-73	-70	-65	-62	-59	-55
Treasury Stock	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66
Accumulated Other Comprehensive Income / (Loss)	-4.29	-3.84	-3.91	-3.96	-4.06	-4.16	-4.08	-3.95

This table displays calculated financial ratios and metrics derived from CareCloud's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	11,066,086.00	10,300,378.00	11,530,591.00	11,829,758.00	12,219,148.00	13,187,221.00	14,874,631.00	15,220,208.00	15,873,120.00	16,239,777.00	42,397,039.00
DEI Adjusted Shares Outstanding	11,066,086.00	10,300,378.00	11,530,591.00	11,829,758.00	12,219,148.00	13,187,221.00	14,874,631.00	15,220,208.00	15,873,120.00	16,239,777.00	42,397,039.00
DEI Earnings Per Adjusted Shares Outstanding	-0.44	-0.93	-0.66	-0.59	-0.59	-1.72	-0.75	-0.66	-4.05	-0.27	0.09
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	26.10%	6.12%	29.87%	58.90%	27.49%	63.13%	32.80%	-0.55%	-15.68%	-5.32%	8.72%
EBITDA Growth	122.44%	-1,016.27%	103.86%	690.39%	406.81%	8.13%	313.60%	9.62%	-243.47%	181.68%	10.94%
EBIT Growth	-2.68%	-85.50%	47.32%	51.18%	72.72%	-1,381.00%	141.54%	73.99%	-903.58%	118.38%	25.56%
NOPAT Growth	-10.32%	-77.22%	42.76%	43.84%	102.64%	-12,444.78%	157.76%	91.44%	-615.21%	127.10%	24.60%
Net Income Growth	-3.95%	-87.67%	36.74%	61.57%	59.22%	-910.67%	132.18%	91.54%	-996.06%	116.13%	37.54%
EPS Growth	0.00%	0.00%	27.37%	14.49%	-1.69%	-198.33%	0.00%	0.00%	-513.43%	93.19%	135.71%
Operating Cash Flow Growth	30.27%	52.76%	131.67%	2,318.84%	11.82%	-111.71%	1,594.84%	58.62%	-26.90%	33.51%	38.36%
Free Cash Flow Firm Growth	96.44%	-1,184.82%	72.81%	-406.32%	117.65%	-3,418.21%	81.07%	143.58%	169.77%	-13.44%	-77.09%
Invested Capital Growth	-13.63%	16.72%	-5.15%	54.29%	-7.20%	240.61%	18.60%	0.96%	-46.80%	-6.92%	16.33%
Revenue Q/Q Growth	-7.02%	16.49%	-1.66%	19.42%	-1.16%	18.32%	4.04%	-3.43%	-3.40%	-0.16%	5.41%
EBITDA Q/Q Growth	229.97%	-5,001.11%	104.36%	-6.41%	35.40%	153.51%	22.96%	-13.81%	-341.06%	219.86%	1.70%
EBIT Q/Q Growth	9.47%	-69.52%	45.79%	-16.85%	63.89%	-1.59%	3,249.54%	-35.31%	-1,288.03%	122.92%	-3.72%
NOPAT Q/Q Growth	8.50%	-69.67%	42.20%	-19.44%	104.03%	-5.79%	9,648.93%	-30.42%	-1,762.25%	133.63%	-3.23%
Net Income Q/Q Growth	3.99%	-57.84%	40.83%	-22.51%	51.03%	-2.06%	633.08%	-35.75%	-985.75%	120.06%	-3.64%
EPS Q/Q Growth	0.00%	0.00%	34.29%	-28.26%	10.45%	-8.48%	0.00%	0.00%	0.00%	91.57%	150.00%
Operating Cash Flow Q/Q Growth	26.86%	-89.29%	116.46%	7.49%	11.74%	39.27%	25.19%	-0.36%	-12.99%	7.77%	13.72%
Free Cash Flow Firm Q/Q Growth	0.00%	-666.38%	73.14%	9.43%	25.78%	-1.72%	13.37%	12.41%	328.31%	-42.59%	2,603.58%
Invested Capital Q/Q Growth	-6.00%	26.27%	0.51%	-4.85%	-2.21%	0.27%	1.63%	-1.72%	-44.96%	1.42%	-4.04%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	39.50%	100.00%	100.00%
EBITDA Margin	1.35%	-11.62%	0.35%	1.72%	6.83%	4.53%	14.10%	15.54%	-26.45%	22.81%	23.28%
Operating Margin	-19.32%	-32.26%	-14.22%	-5.02%	0.10%	-7.87%	2.53%	4.76%	-40.25%	8.23%	9.41%
EBIT Margin	-18.58%	-32.48%	-13.17%	-4.05%	-0.87%	-7.86%	2.46%	4.30%	-41.00%	7.96%	9.19%
Profit (Net Income) Margin	-20.31%	-35.91%	-17.49%	-4.23%	-1.35%	-8.38%	2.03%	3.91%	-41.58%	7.08%	8.96%
Tax Burden Percent	103.03%	102.29%	101.23%	93.14%	128.42%	101.18%	94.75%	96.84%	99.26%	98.00%	98.19%
Interest Burden Percent	106.10%	108.12%	131.20%	112.24%	121.68%	105.40%	87.18%	93.91%	102.17%	90.80%	99.27%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.25%	3.16%	0.00%	2.00%	1.81%
Return on Invested Capital (ROIC)	-18.37%	-32.42%	-17.68%	-8.02%	0.18%	-10.53%	3.60%	6.32%	-42.30%	17.10%	20.43%
ROIC Less NNEP Spread (ROIC-NNEP)	-84.21%	-86.14%	-74.22%	-3.15%	6.34%	7.19%	11.20%	-58.92%	-292.94%	0.44%	301.21%
Return on Net Nonoperating Assets (RNNOA)	-13.72%	-47.70%	-23.06%	0.79%	-2.32%	-1.70%	-0.75%	-0.88%	-25.58%	0.06%	-0.67%
Return on Equity (ROE)	-32.09%	-80.12%	-40.74%	-7.23%	-2.13%	-12.23%	2.85%	5.44%	-67.88%	17.16%	19.76%
Cash Return on Invested Capital (CROIC)	-3.74%	-47.85%	-12.40%	-50.72%	7.65%	-119.75%	-13.42%	5.36%	18.79%	24.26%	5.33%
Operating Return on Assets (OROA)	-17.23%	-28.92%	-15.56%	-5.59%	-1.07%	-8.50%	2.46%	4.31%	-44.86%	11.81%	13.92%
Return on Assets (ROA)	-18.83%	-31.99%	-20.67%	-5.85%	-1.68%	-9.07%	2.03%	3.92%	-45.49%	10.51%	13.56%
Return on Common Equity (ROCE)	-32.09%	-80.12%	-40.74%	-7.23%	-2.13%	-12.23%	2.85%	5.44%	-67.88%	17.16%	19.76%
Return on Equity Simple (ROE_SIMPLE)	-31.48%	-124.48%	-27.48%	-5.50%	-2.04%	-8.70%	2.90%	5.34%	-116.68%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.12	-5.53	-3.17	-1.78	0.05	-5.79	3.34	6.40	-33	8.94	11
NOPAT Margin	-13.52%	-22.58%	-9.95%	-3.52%	0.07%	-5.51%	2.40%	4.61%	-28.17%	8.06%	9.24%
Net Nonoperating Expense Percent (NNEP)	65.84%	53.72%	56.53%	-4.87%	-6.16%	-17.72%	-7.60%	65.24%	250.63%	16.66%	-280.78%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-63.37%	17.84%	18.09%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	60.50%	0.00%	0.00%
SG&A Expenses to Revenue	51.86%	50.87%	36.90%	32.18%	27.80%	21.70%	17.39%	77.98%	18.34%	69.44%	68.75%
R&D to Revenue	2.86%	3.68%	3.40%	2.04%	1.35%	8.86%	3.16%	3.17%	4.05%	3.41%	5.30%
Operating Expenses to Revenue	119.32%	132.26%	114.22%	105.02%	99.90%	107.87%	97.47%	95.24%	79.75%	91.77%	90.59%
Earnings before Interest and Taxes (EBIT)	-4.29	-7.95	-4.19	-2.05	-0.56	-8.26	3.43	5.97	-48	8.82	11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.31	-2.85	0.11	0.87	4.40	4.76	20	22	-31	25	28
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.89	1.06	1.49	1.16	1.16	1.18	0.96	0.42	0.58	1.19	2.08
Price to Tangible Book Value (P/TBV)	24.58	0.00	5.50	2.29	2.05	5.44	15.77	3.90	0.00	5.00	13.61
Price to Revenue (P/Rev)	0.58	0.30	0.95	0.89	0.77	1.14	0.67	0.31	0.21	0.54	1.03
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	31.81
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.14%
Enterprise Value to Invested Capital (EV/IC)	0.89	1.01	1.52	1.17	1.20	1.17	0.92	0.38	0.57	1.08	2.09
Enterprise Value to Revenue (EV/Rev)	0.61	0.76	0.83	0.62	0.47	0.94	0.67	0.28	0.27	0.49	1.01
Enterprise Value to EBITDA (EV/EBITDA)	44.98	0.00	241.46	36.29	6.81	20.83	4.73	1.80	0.00	2.16	4.36
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	27.10	6.50	0.00	6.19	11.04
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	639.33	0.00	27.82	6.06	0.00	6.11	10.98
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	94.19	4.63	3.94	0.00	6.98	1.83	2.01	2.65	4.28
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	15.11	0.00	0.00	7.15	2.12	4.31	42.08
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.59	2.06	0.04	0.03	0.01	0.00	0.10	0.08	0.25	0.01	0.03
Long-Term Debt to Equity	0.33	0.59	0.01	0.01	0.00	0.00	0.08	0.08	0.24	0.00	0.01
Financial Leverage	0.16	0.55	0.31	-0.25	-0.37	-0.24	-0.07	0.01	0.09	0.14	0.00
Leverage Ratio	1.70	2.50	1.97	1.24	1.27	1.35	1.40	1.39	1.49	1.63	1.46
Compound Leverage Factor	1.81	2.71	2.59	1.39	1.55	1.42	1.22	1.30	1.52	1.48	1.45
Debt to Total Capital	36.96%	67.36%	3.78%	2.57%	0.85%	0.43%	8.73%	7.57%	19.85%	0.67%	3.37%
Short-Term Debt to Total Capital	16.21%	47.96%	3.20%	2.02%	0.66%	0.39%	1.25%	0.29%	0.56%	0.62%	2.66%
Long-Term Debt to Total Capital	20.75%	19.40%	0.57%	0.56%	0.19%	0.04%	7.47%	7.28%	19.28%	0.05%	0.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.01%	0.01%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	63.04%	32.64%	96.22%	97.42%	99.15%	99.56%	91.27%	92.42%	80.14%	99.32%	96.62%
Debt to EBITDA	28.11	-5.12	7.24	1.18	0.08	0.09	0.48	0.39	-0.33	0.01	0.07
Net Debt to EBITDA	2.23	-3.90	-32.47	-15.48	-4.46	-4.30	-0.05	-0.18	-0.23	-0.19	-0.05
Long-Term Debt to EBITDA	15.78	-1.48	1.10	0.26	0.02	0.01	0.41	0.37	-0.32	0.00	0.02
Debt to NOPAT	-2.80	-2.64	-0.25	-0.58	7.83	-0.08	2.80	1.30	-0.31	0.04	0.19
Net Debt to NOPAT	-0.22	-2.01	1.13	7.56	-418.49	3.54	-0.29	-0.62	-0.21	-0.54	-0.14
Long-Term Debt to NOPAT	-1.57	-0.76	-0.04	-0.13	1.77	-0.01	2.40	1.25	-0.30	0.00	0.04
Altman Z-Score	0.76	-1.05	3.05	3.74	3.10	2.31	2.13	1.75	-1.47	2.37	3.56
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.01%	0.01%	0.01%	0.00%	0.01%	0.01%	0.01%	0.01%	0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.89	0.53	2.07	3.20	2.77	1.54	1.20	1.55	1.00	1.27	1.05
Quick Ratio	1.78	0.49	1.91	2.68	2.42	1.14	0.89	1.21	0.65	0.92	0.75
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-0.64	-8.16	-2.22	-11	1.98	-66	-12	5.43	15	13	2.91
Operating Cash Flow to CapEx	-446.31%	-191.92%	40.40%	662.53%	297.81%	-11.51%	126.22%	817.27%	504.77%	1,216.38%	597.76%
Free Cash Flow to Firm to Interest Expense	-2.20	-11.97	-1.68	-32.01	5.18	-134.91	-27.39	13.41	12.27	14.09	10.12
Operating Cash Flow to Interest Expense	-6.53	-1.30	0.21	19.40	19.89	-1.83	29.31	52.22	12.95	22.94	99.52
Operating Cash Flow Less CapEx to Interest Expense	-7.99	-1.98	-0.31	16.47	13.21	-17.71	6.09	45.83	10.38	21.05	82.87
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.93	0.89	1.18	1.38	1.24	1.08	1.00	1.00	1.09	1.48	1.51
Accounts Receivable Turnover	8.78	7.46	7.71	8.98	8.97	11.00	9.59	8.73	8.77	8.98	8.65
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	167.42	0.00	0.00
Fixed Asset Turnover	16.39	16.54	21.39	31.42	27.19	26.85	27.04	26.54	22.57	20.90	18.45
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.34	0.00	0.00
Days Sales Outstanding (DSO)	41.57	48.95	47.32	40.66	40.68	33.18	38.05	41.80	41.62	40.66	42.21
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.18	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	29.58	0.00	0.00
Cash Conversion Cycle (CCC)	41.57	48.95	47.32	40.66	40.68	33.18	38.05	41.80	14.21	40.66	42.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	16	18	17	27	25	85	101	102	54	50	59
Invested Capital Turnover	1.36	1.44	1.78	2.28	2.49	1.91	1.50	1.37	1.50	2.12	2.21
Increase / (Decrease) in Invested Capital	-2.49	2.63	-0.95	9.46	-1.94	60	16	0.97	-48	-3.75	8.23
Enterprise Value (EV)	14	19	27	32	30	99	93	39	31	55	122
Market Capitalization	13	7.47	30	45	50	120	94	43	24	59	124
Book Value per Share	$1.35	$0.69	$1.76	$3.29	$3.51	$7.68	$6.58	$6.68	$2.63	$3.06	$1.40
Tangible Book Value per Share	$0.05	($1.06)	$0.47	$1.66	$1.98	$1.67	$0.40	$0.72	($0.16)	$0.73	$0.21
Total Capital	24	22	21	40	43	102	107	110	52	50	62
Total Debt	8.73	15	0.80	1.03	0.37	0.44	9.36	8.33	10	0.34	2.08
Total Long-Term Debt	4.90	4.20	0.12	0.22	0.08	0.04	8.02	8.01	10	0.03	0.44
Net Debt	0.69	11	-3.57	-13	-20	-20	-0.98	-3.97	7.00	-4.81	-1.54
Capital Expenditures (CapEx)	0.42	0.46	0.70	1.03	2.56	7.75	11	2.59	3.06	1.70	4.78
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.92	-0.51	0.92	4.25	0.11	-4.73	-3.00	0.28	-3.10	0.39	-0.67
Debt-free Net Working Capital (DFNWC)	8.96	2.97	5.28	19	20	16	7.34	13	0.24	5.53	2.95
Net Working Capital (NWC)	5.13	-7.42	4.61	18	20	16	6.00	12	-0.06	5.22	1.32
Net Nonoperating Expense (NNE)	1.57	3.27	2.40	0.36	0.92	3.02	0.51	0.97	16	1.09	0.34
Net Nonoperating Obligations (NNO)	0.85	11	-2.82	-12	-18	-16	2.88	0.09	12	0.63	-0.87
Total Depreciation and Amortization (D&A)	4.60	5.11	4.30	2.91	4.96	13	16	16	17	16	17
Debt-free, Cash-free Net Working Capital to Revenue	3.97%	-2.09%	2.89%	8.40%	0.18%	-4.50%	-2.15%	0.20%	-2.64%	0.35%	-0.55%
Debt-free Net Working Capital to Revenue	38.81%	12.11%	16.60%	37.04%	31.20%	15.41%	5.26%	9.06%	0.20%	4.99%	2.45%
Net Working Capital to Revenue	22.22%	-30.29%	14.48%	35.44%	30.76%	15.03%	4.30%	8.83%	-0.05%	4.71%	1.09%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.69)	($0.59)	($0.60)	($1.79)	($0.77)	($0.67)	($4.11)	$0.00	$0.10
Adjusted Weighted Average Basic Shares Outstanding	10.33M	10.42M	11.67M	12.01M	12.34M	14.05M	15.04M	15.11M	15.67M	0.00	37.79M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.69)	($0.59)	($0.60)	($1.79)	($0.77)	$0.00	($4.11)	$0.00	$0.10
Adjusted Weighted Average Diluted Shares Outstanding	10.33M	10.42M	11.67M	12.01M	12.34M	14.05M	15.04M	15.51M	15.67M	0.00	37.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($0.69)	($0.59)	($0.60)	($1.79)	($0.77)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.51M	16.12M	0.00	42.49M
Normalized Net Operating Profit after Tax (NOPAT)	-4.37	-6.03	-2.87	-1.73	-0.04	-5.82	2.86	4.51	-2.81	9.52	11
Normalized NOPAT Margin	-18.94%	-24.63%	-9.01%	-3.42%	-0.06%	-5.53%	2.05%	3.25%	-2.40%	8.59%	9.37%
Pre Tax Income Margin	-19.71%	-35.11%	-17.28%	-4.54%	-1.05%	-8.29%	2.14%	4.04%	-41.89%	7.23%	9.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-14.87	-11.66	-3.16	-5.82	-1.46	-16.93	7.55	14.75	-40.20	9.80	38.60
NOPAT to Interest Expense	-10.82	-8.11	-2.39	-5.06	0.12	-11.86	7.35	15.81	-27.62	9.93	38.81
EBIT Less CapEx to Interest Expense	-16.33	-12.34	-3.69	-8.75	-8.14	-32.82	-15.67	8.36	-42.76	7.92	21.95
NOPAT Less CapEx to Interest Expense	-12.28	-8.79	-2.92	-7.99	-6.56	-27.75	-15.87	9.42	-30.19	8.05	22.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-1.02%	-8.06%	-26.70%	-191.84%	-700.57%	-129.15%	509.06%	281.92%	-29.38%	0.00%	58.30%
Augmented Payout Ratio	-3.62%	-14.27%	-26.70%	-191.84%	-700.57%	-129.15%	511.88%	282.51%	-29.38%	0.00%	58.30%

This table displays calculated financial ratios and metrics derived from CareCloud's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	15,628,097.00	15,873,120.00	16,118,492.00	16,120,767.00	16,213,607.00	16,239,777.00	84,633,026.00	42,321,129.00	42,322,039.00	42,397,039.00	42,492,949.00
DEI Adjusted Shares Outstanding	15,628,097.00	15,873,120.00	16,118,492.00	16,120,767.00	16,213,607.00	16,239,777.00	84,633,026.00	42,321,129.00	42,322,039.00	42,397,039.00	42,492,949.00
DEI Earnings Per Adjusted Shares Outstanding	-0.43	-3.00	-0.10	-0.14	-0.04	0.00	-0.01	0.04	0.04	0.04	-0.01
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-13.18%	-12.66%	-13.46%	-4.33%	-2.51%	-0.62%	6.43%	-2.54%	8.83%	21.90%	13.17%
EBITDA Growth	-58.11%	-947.01%	26.70%	155.77%	242.89%	118.40%	26.30%	8.86%	7.21%	6.51%	-5.47%
EBIT Growth	-300.50%	-7,242.28%	166.02%	234.03%	239.01%	107.71%	1,374.26%	49.77%	-5.11%	-12.64%	-49.03%
NOPAT Growth	-185.95%	-3,520.48%	157.85%	345.96%	333.70%	111.18%	2,089.79%	33.07%	-1.77%	-10.91%	-52.13%
Net Income Growth	-360.32%	-8,855.91%	39.90%	191.38%	213.57%	107.54%	908.30%	73.36%	-1.99%	-12.38%	-52.67%
EPS Growth	-133.33%	0.00%	64.29%	62.16%	90.48%	0.00%	60.00%	128.57%	200.00%	0.00%	75.00%
Operating Cash Flow Growth	-38.18%	-38.16%	297.46%	-32.98%	63.88%	39.81%	25.75%	73.12%	4.20%	65.90%	-29.38%
Free Cash Flow Firm Growth	237.97%	22,279.52%	4,996.57%	1,307.18%	1,260.99%	-58.11%	-90.39%	-86.03%	-115.87%	-172.51%	-245.71%
Invested Capital Growth	-5.01%	-46.80%	-50.14%	-48.83%	-49.48%	-6.92%	-5.87%	-8.16%	22.94%	16.33%	16.92%
Revenue Q/Q Growth	-0.28%	-2.95%	-8.64%	8.20%	1.62%	-1.08%	-2.15%	-0.92%	13.48%	10.80%	-9.16%
EBITDA Q/Q Growth	-15.12%	-1,981.56%	111.91%	34.49%	13.79%	0.97%	-18.26%	15.92%	12.06%	0.30%	-27.45%
EBIT Q/Q Growth	-62.17%	-1,736.33%	100.31%	1,353.68%	68.18%	1.80%	-40.77%	47.68%	6.55%	-6.28%	-65.44%
NOPAT Q/Q Growth	-52.83%	-2,114.87%	100.30%	2,357.69%	45.21%	5.92%	-42.07%	49.35%	7.19%	-3.93%	-68.87%
Net Income Q/Q Growth	-50.05%	-1,489.38%	99.45%	794.61%	86.50%	5.57%	-40.90%	48.97%	5.44%	-5.62%	-68.07%
EPS Q/Q Growth	-13.51%	-623.81%	96.71%	-40.00%	71.43%	0.00%	0.00%	200.00%	0.00%	50.00%	-116.67%
Operating Cash Flow Q/Q Growth	-32.45%	-13.29%	8.72%	5.24%	65.18%	-26.02%	-2.22%	44.89%	-0.58%	17.79%	-58.37%
Free Cash Flow Firm Q/Q Growth	5.11%	348.20%	206.03%	-2.39%	1.66%	-86.21%	-29.80%	41.87%	-215.53%	36.98%	-41.06%
Invested Capital Q/Q Growth	-1.62%	-44.96%	-4.11%	-1.46%	-2.86%	1.42%	-3.03%	-3.86%	30.04%	-4.04%	-2.54%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.64%	40.27%	41.54%	45.74%	45.98%	262.33%	100.00%	47.11%	47.78%	234.12%	100.00%
EBITDA Margin	7.11%	-137.86%	17.97%	22.34%	25.01%	25.53%	21.32%	24.95%	24.64%	22.30%	17.81%
Operating Margin	-6.73%	-153.55%	0.50%	8.08%	11.44%	12.24%	7.31%	10.94%	10.33%	9.06%	3.20%
EBIT Margin	-8.17%	-154.58%	0.52%	7.04%	11.65%	11.99%	7.26%	10.82%	10.16%	8.59%	3.27%
Profit (Net Income) Margin	-9.39%	-153.76%	-0.93%	5.96%	10.94%	11.67%	7.05%	10.60%	9.85%	8.39%	2.95%
Tax Burden Percent	102.12%	98.72%	119.31%	97.72%	98.70%	98.77%	97.94%	98.57%	98.61%	97.53%	94.66%
Interest Burden Percent	112.54%	100.76%	-148.53%	86.65%	95.13%	98.58%	99.20%	99.43%	98.35%	100.14%	95.30%
Effective Tax Rate	0.00%	0.00%	0.00%	2.28%	1.30%	1.23%	2.06%	1.43%	1.39%	2.47%	5.34%
Return on Invested Capital (ROIC)	-5.65%	-161.38%	0.50%	11.68%	16.93%	25.63%	15.98%	24.57%	21.03%	19.53%	7.09%
ROIC Less NNEP Spread (ROIC-NNEP)	-30.66%	-371.38%	-3.50%	4.10%	15.43%	23.83%	14.84%	33.35%	17.77%	146.08%	7.85%
Return on Net Nonoperating Assets (RNNOA)	-1.76%	-32.43%	-0.42%	0.43%	1.54%	3.40%	0.81%	-0.39%	1.11%	-0.32%	-0.45%
Return on Equity (ROE)	-7.41%	-193.81%	0.09%	12.11%	18.46%	29.03%	16.78%	24.18%	22.13%	19.20%	6.64%
Cash Return on Invested Capital (CROIC)	3.39%	18.79%	24.96%	24.59%	29.84%	24.26%	27.55%	32.08%	0.19%	5.33%	3.47%
Operating Return on Assets (OROA)	-7.70%	-169.11%	0.57%	7.83%	13.15%	17.78%	10.85%	16.20%	14.40%	13.00%	5.06%
Return on Assets (ROA)	-8.85%	-168.21%	-1.01%	6.63%	12.35%	17.31%	10.54%	15.88%	13.96%	12.70%	4.57%
Return on Common Equity (ROCE)	-7.41%	-193.80%	0.09%	12.11%	18.46%	29.03%	16.78%	24.18%	22.13%	19.20%	6.64%
Return on Equity Simple (ROE_SIMPLE)	-5.09%	0.00%	-117.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.38	-31	0.09	2.22	3.22	3.41	1.98	2.95	3.17	3.04	0.95
NOPAT Margin	-4.71%	-107.49%	0.35%	7.90%	11.29%	12.09%	7.16%	10.79%	10.19%	8.83%	3.03%
Net Nonoperating Expense Percent (NNEP)	25.00%	210.00%	4.00%	7.58%	1.50%	1.80%	1.13%	-8.78%	3.25%	-126.55%	-0.76%
Return On Investment Capital (ROIC_SIMPLE)	-	-58.68%	0.18%	4.59%	6.85%	6.81%	3.64%	5.21%	4.84%	4.94%	1.58%
Cost of Revenue to Revenue	62.36%	59.73%	58.46%	54.26%	54.02%	-162.33%	0.00%	52.89%	52.22%	-134.12%	0.00%
SG&A Expenses to Revenue	18.72%	17.41%	14.33%	14.34%	15.34%	229.60%	71.64%	15.92%	15.73%	201.22%	71.46%
R&D to Revenue	4.30%	4.27%	3.52%	3.76%	2.80%	3.59%	4.47%	3.73%	5.10%	7.39%	7.73%
Operating Expenses to Revenue	44.36%	193.82%	41.04%	37.65%	34.54%	250.09%	92.69%	36.17%	37.44%	225.06%	96.80%
Earnings before Interest and Taxes (EBIT)	-2.39	-44	0.14	1.98	3.33	3.39	2.01	2.96	3.16	2.96	1.02
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2.08	-39	4.67	6.27	7.14	7.21	5.89	6.83	7.65	7.68	5.57
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.20	0.58	0.45	0.72	0.92	1.19	1.09	1.78	2.35	2.08	2.66
Price to Tangible Book Value (P/TBV)	66.32	0.00	0.00	12.11	5.94	5.00	3.25	4.67	22.15	13.61	14.93
Price to Revenue (P/Rev)	0.15	0.21	0.17	0.28	0.39	0.54	0.52	0.89	1.19	1.03	1.25
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5,875.17	57.11	31.81	35.97
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%	1.75%	3.14%	2.78%
Enterprise Value to Invested Capital (EV/IC)	0.24	0.57	0.46	0.65	0.82	1.08	1.07	1.92	2.27	2.09	2.68
Enterprise Value to Revenue (EV/Rev)	0.20	0.27	0.21	0.30	0.37	0.49	0.46	0.81	1.21	1.01	1.23
Enterprise Value to EBITDA (EV/EBITDA)	1.87	0.00	0.00	0.00	0.00	2.16	1.97	3.33	5.02	4.36	5.52
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	6.19	4.88	7.71	12.03	11.04	15.15
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	6.11	4.82	7.79	12.03	10.98	15.14
Enterprise Value to Operating Cash Flow (EV/OCF)	1.35	2.01	1.28	2.04	2.12	2.65	2.41	3.63	5.51	4.28	5.65
Enterprise Value to Free Cash Flow (EV/FCFF)	7.04	2.12	1.22	1.80	1.84	4.31	3.76	5.72	1,288.07	42.08	83.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.14	0.25	0.22	0.12	0.01	0.01	0.00	0.01	0.13	0.03	0.03
Long-Term Debt to Equity	0.14	0.24	0.22	0.12	0.00	0.00	0.00	0.00	0.12	0.01	0.00
Financial Leverage	0.06	0.09	0.12	0.11	0.10	0.14	0.05	-0.01	0.06	0.00	-0.06
Leverage Ratio	1.35	1.49	1.49	1.47	1.46	1.63	1.57	1.50	1.55	1.46	1.42
Compound Leverage Factor	1.52	1.50	-2.21	1.27	1.39	1.61	1.56	1.49	1.52	1.46	1.36
Debt to Total Capital	12.42%	19.85%	18.18%	10.55%	1.14%	0.67%	0.37%	1.12%	11.70%	3.37%	2.87%
Short-Term Debt to Total Capital	0.49%	0.56%	0.33%	0.14%	1.08%	0.62%	0.33%	0.97%	1.41%	2.66%	2.46%
Long-Term Debt to Total Capital	11.93%	19.28%	17.85%	10.41%	0.06%	0.05%	0.04%	0.15%	10.28%	0.72%	0.42%
Preferred Equity to Total Capital	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.58%	80.14%	81.81%	89.44%	98.85%	99.32%	99.62%	98.87%	88.30%	96.62%	97.12%
Debt to EBITDA	0.97	-0.33	-0.31	-0.20	-0.03	0.01	0.01	0.02	0.28	0.07	0.06
Net Debt to EBITDA	0.47	-0.23	-0.17	-0.09	0.11	-0.19	-0.25	-0.36	0.09	-0.05	-0.08
Long-Term Debt to EBITDA	0.94	-0.32	-0.30	-0.19	0.00	0.00	0.00	0.00	0.24	0.02	0.01
Debt to NOPAT	-7.06	-0.31	-0.28	-0.17	-0.02	0.04	0.02	0.06	0.67	0.19	0.17
Net Debt to NOPAT	-3.44	-0.21	-0.15	-0.08	0.08	-0.54	-0.61	-0.85	0.22	-0.14	-0.21
Long-Term Debt to NOPAT	-6.78	-0.30	-0.28	-0.17	0.00	0.00	0.00	0.01	0.58	0.04	0.02
Altman Z-Score	0.90	-1.30	0.44	0.83	1.42	2.12	2.40	3.83	3.04	3.26	3.90
Noncontrolling Interest Sharing Ratio	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.25	1.00	1.02	1.03	1.03	1.27	1.69	1.91	1.26	1.05	1.11
Quick Ratio	0.86	0.65	0.68	0.68	0.67	0.92	1.22	1.48	0.84	0.75	0.79
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3.81	17	52	51	52	7.16	5.03	7.13	-8.24	-5.19	-7.32
Operating Cash Flow to CapEx	404.60%	994.68%	1,364.43%	3,369.29%	2,116.17%	557.46%	819.39%	637.52%	847.53%	408.62%	876.46%
Free Cash Flow to Firm to Interest Expense	10.83	46.82	143.29	177.25	289.91	105.27	86.64	104.84	-56.03	-370.78	-126.25
Operating Cash Flow to Interest Expense	12.25	10.25	11.14	14.86	39.49	76.90	88.16	108.94	50.10	619.64	62.26
Operating Cash Flow Less CapEx to Interest Expense	9.22	9.22	10.32	14.42	37.62	63.10	77.40	91.85	44.19	468.00	55.16
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.94	1.09	1.09	1.11	1.13	1.48	1.50	1.50	1.42	1.51	1.55
Accounts Receivable Turnover	8.46	8.77	8.49	8.89	9.11	8.98	8.69	8.38	8.36	8.65	8.52
Inventory Turnover	120.19	167.42	182.25	146.06	126.64	0.00	0.00	118.37	109.33	0.00	0.00
Fixed Asset Turnover	23.26	22.57	22.70	22.80	21.74	20.90	20.91	20.54	20.40	18.45	19.42
Accounts Payable Turnover	9.96	12.34	12.22	12.36	10.64	0.00	0.00	12.49	9.98	0.00	0.00
Days Sales Outstanding (DSO)	43.14	41.62	43.02	41.04	40.06	40.66	41.98	43.54	43.65	42.21	42.86
Days Inventory Outstanding (DIO)	3.04	2.18	2.00	2.50	2.88	0.00	0.00	3.08	3.34	0.00	0.00
Days Payable Outstanding (DPO)	36.64	29.58	29.87	29.54	34.31	0.00	0.00	29.21	36.58	0.00	0.00
Cash Conversion Cycle (CCC)	9.53	14.21	15.15	14.00	8.63	40.66	41.98	17.42	10.41	42.21	42.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	98	54	52	51	50	50	49	47	61	59	57
Invested Capital Turnover	1.20	1.50	1.45	1.48	1.50	2.12	2.23	2.28	2.06	2.21	2.34
Increase / (Decrease) in Invested Capital	-5.19	-48	-52	-49	-49	-3.75	-3.05	-4.18	11	8.23	8.27
Enterprise Value (EV)	24	31	24	33	41	55	52	90	138	122	153
Market Capitalization	18	24	19	31	43	59	59	100	136	124	155
Book Value per Share	$5.64	$2.63	$2.57	$2.68	$2.87	$3.06	$1.28	$1.33	$1.37	$1.40	$1.37
Tangible Book Value per Share	$0.02	($0.16)	($0.06)	$0.16	$0.44	$0.73	$0.43	$0.50	$0.14	$0.21	$0.24
Total Capital	101	52	51	48	47	50	54	57	65	62	60
Total Debt	13	10	9.20	5.10	0.54	0.34	0.20	0.64	7.66	2.08	1.73
Total Long-Term Debt	12	10	9.04	5.03	0.03	0.03	0.02	0.09	6.73	0.44	0.25
Net Debt	6.09	7.00	5.06	2.48	-2.25	-4.81	-6.60	-9.80	2.58	-1.54	-2.13
Capital Expenditures (CapEx)	1.07	0.38	0.30	0.13	0.33	0.94	0.62	1.16	0.87	2.12	0.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.37	-3.10	-3.50	-1.88	-1.54	0.39	5.04	4.96	1.91	-0.67	0.25
Debt-free Net Working Capital (DFNWC)	6.04	0.24	0.64	0.74	1.24	5.53	12	15	6.99	2.95	4.10
Net Working Capital (NWC)	5.55	-0.06	0.47	0.67	0.73	5.22	12	15	6.06	1.32	2.63
Net Nonoperating Expense (NNE)	1.37	13	0.33	0.55	0.10	0.12	0.03	0.05	0.11	0.15	0.02
Net Nonoperating Obligations (NNO)	10	12	11	7.92	3.19	0.63	-5.30	-9.09	3.30	-0.87	-1.18
Total Depreciation and Amortization (D&A)	4.47	4.75	4.53	4.30	3.81	3.82	3.89	3.87	4.50	4.72	4.55
Debt-free, Cash-free Net Working Capital to Revenue	-0.30%	-2.64%	-3.09%	-1.68%	-1.39%	0.35%	4.48%	4.44%	1.67%	-0.55%	0.20%
Debt-free Net Working Capital to Revenue	4.98%	0.20%	0.57%	0.66%	1.12%	4.99%	10.53%	13.78%	6.11%	2.45%	3.31%
Net Working Capital to Revenue	4.58%	-0.05%	0.42%	0.60%	0.66%	4.71%	10.37%	13.28%	5.30%	1.09%	2.12%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.42)	($3.04)	($0.02)	($0.14)	($0.04)	$0.00	($0.04)	$0.04	$0.04	$0.06	($0.01)
Adjusted Weighted Average Basic Shares Outstanding	15.76M	15.67M	16.01M	16.13M	16.20M	16.15M	23.81M	42.32M	42.37M	37.79M	42.47M
Adjusted Diluted Earnings per Share	($0.42)	($3.04)	($0.02)	($0.14)	($0.04)	$0.00	($0.04)	$0.04	$0.04	$0.06	($0.01)
Adjusted Weighted Average Diluted Shares Outstanding	15.76M	15.67M	16.01M	16.13M	16.20M	16.15M	23.81M	42.32M	42.37M	37.95M	42.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	15.87M	16.12M	16.12M	16.21M	16.24M	42.32M	42.32M	42.32M	42.40M	42.49M	42.49M
Normalized Net Operating Profit after Tax (NOPAT)	-1.37	-30	0.32	2.33	3.29	3.50	2.09	2.98	3.18	3.04	1.00
Normalized NOPAT Margin	-4.69%	-105.82%	1.22%	8.30%	11.52%	12.41%	7.56%	10.87%	10.24%	8.83%	3.20%
Pre Tax Income Margin	-9.19%	-155.76%	-0.78%	6.10%	11.08%	11.82%	7.20%	10.75%	9.99%	8.60%	3.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-6.80	-120.34	0.37	6.86	18.58	49.78	34.57	43.54	21.46	211.21	17.62
NOPAT to Interest Expense	-3.92	-83.68	0.25	7.71	18.00	50.20	34.09	43.43	21.53	217.22	16.32
EBIT Less CapEx to Interest Expense	-9.82	-121.37	-0.44	6.42	16.71	35.99	23.81	26.46	15.55	59.57	10.52
NOPAT Less CapEx to Interest Expense	-6.95	-84.71	-0.57	7.26	16.14	36.41	23.33	26.34	15.62	65.58	9.22
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-346.35%	-29.38%	-21.49%	-14.49%	-6.67%	0.00%	17.23%	29.44%	43.02%	58.30%	66.32%
Augmented Payout Ratio	-346.35%	-29.38%	-21.49%	-14.49%	-6.67%	0.00%	17.23%	29.44%	43.02%	58.30%	66.32%

Financials Breakdown Chart

Key Financial Trends

CareCloud’s latest quarter shows a sharp improvement in operating performance, but the broader balance sheet and capital structure still look complicated. In Q1 2026, the company generated $31.3 million in revenue, posted $1.0 million in operating income, and produced $3.6 million in operating cash flow. That’s a meaningful step up from the same quarter a year ago, when CareCloud was still losing money on a common-share basis.

Revenue held up well year over year. Q1 2026 revenue was $31.27 million, up slightly from $27.63 million in Q1 2025, showing the top line is still growing.
Operating results turned positive again. Q1 2026 operating income was $1.0 million versus $2.02 million in Q1 2025 and a loss in Q1 2024, indicating the business is back in the black at the operating level.
Operating cash flow remained solid. The company generated $3.61 million in operating cash flow in Q1 2026, which supports day-to-day liquidity.
Net income improved meaningfully. CareCloud reported $922,000 in consolidated net income in Q1 2026, compared with a loss in Q1 2024 and stronger but still modest profits in recent 2025 quarters.
Quarter-end liquidity improved slightly. Cash and equivalents rose to $3.35 million at March 31, 2026 from $2.62 million at the end of Q2 2024, and the company also held $500,000 of restricted cash.
Debt levels declined versus a year earlier. Total debt was much lower than in prior periods, with short-term debt of $1.48 million and long-term debt of just $250,000 at the end of Q1 2026.
Cash generation has been supported by non-cash expenses. Depreciation and amortization remain material, which helps operating cash flow but also reflects a business with meaningful fixed and acquired asset bases.
Preferred stock dividends continue to weigh on common shareholders. Although the company is profitable on a consolidated basis, common shareholders saw a loss after preferred dividends in some earlier periods, and those dividends remain an important capital structure factor.
Revenue growth slowed from the stronger 2025 run rate. Q1 2026 revenue was below Q4 2025’s $34.4 million, suggesting seasonal or cyclical pressure.
Balance sheet leverage and equity composition remain a concern. Total liabilities were $28.4 million against $58.3 million of equity, but a large portion of equity is tied up in non-cash items such as common stock and accumulated losses, which limits flexibility.

Looking at the trend over the last four years, CareCloud has clearly improved from the deep losses seen in 2023 and early 2024. Back then, operating income was negative or barely positive, and cash flow was more uneven. Since mid-2024 and through 2025, the company has generally produced positive operating income and positive operating cash flow, which suggests the business model is becoming more stable.

The biggest takeaway for investors: CareCloud’s latest quarter looks healthier than the company’s 2023 and early 2024 performance, with better profitability and cash flow. The main question now is whether it can sustain revenue growth and keep debt and preferred-stock-related obligations from limiting the upside.

07/15/26 09:08 AM ETAI Generated. May Contain Errors.

CareCloud Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CareCloud's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CareCloud's net income appears to be on a downward trend, with a most recent value of $10.80 million in 2025, falling from -$4.69 million in 2015. The previous period was $7.85 million in 2024. View CareCloud's forecast to see where analysts expect CareCloud to go next.

CareCloud's total operating income in 2025 was $11.34 million, based on the following breakdown:

Total Gross Profit: $120.50 million
Total Operating Expenses: $109.16 million

Over the last 10 years, CareCloud's total revenue changed from $23.08 million in 2015 to $120.50 million in 2025, a change of 422.1%.

CareCloud's total liabilities were at $28.09 million at the end of 2025, a 28.6% increase from 2024, and a 138.4% increase since 2015.

In the past 10 years, CareCloud's cash and equivalents has ranged from $3.12 million in 2025 to $20.93 million in 2020, and is currently $3.12 million as of their latest financial filing in 2025.

Over the last 10 years, CareCloud's book value per share changed from 1.35 in 2015 to 1.40 in 2025, a change of 4.3%.

Related Companies

Financial statements for NASDAQ:CCLD last updated on 7/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareCloud (CCLD) Financials

Financials Breakdown Chart

Key Financial Trends

CareCloud Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareCloud (CCLD) Financials

Annual Income Statements for CareCloud

Quarterly Income Statements for CareCloud

Annual Cash Flow Statements for CareCloud

Quarterly Cash Flow Statements for CareCloud

Annual Balance Sheets for CareCloud

Quarterly Balance Sheets for CareCloud

Annual Metrics And Ratios for CareCloud

Quarterly Metrics And Ratios for CareCloud

Financials Breakdown Chart

Key Financial Trends

CareCloud Financials - Frequently Asked Questions

When does CareCloud's fiscal year end?

How has CareCloud's net income changed over the last 10 years?

What is CareCloud's operating income?

How has CareCloud's revenue changed over the last 10 years?

How much debt does CareCloud have?

How much cash does CareCloud have?

How has CareCloud's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools